#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Aspergillus infection Gestational trophoblastic tumour Epilepsy with myoclonic-atonic seizures Epstein-Barr virus infection Hepato-lenticular degeneration Hepatoblastoma Congenital leptin deficiency Mucopolysaccharidosis III Netherton's syndrome Immune thrombocytopenia Stevens-Johnson syndrome Hereditary haemorrhagic telangiectasia Congenital hypotransferrinaemia Palmar-plantar erythrodysaesthesia syndrome Mycobacterium abscessus infection More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Trials in Disease Angelman’s syndrome – Diagnostics Alagille syndrome – Life with Disease Netherton’s syndrome – Life with Disease Nodal marginal zone B-cell lymphoma Osteosarcoma – Diagnostics Crigler-Najjar syndrome – Treatment Glomerulonephritis membranous Glomerulonephritis rapidly progressive Brain stem glioma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tolinapant Lactate Colesevelam Ziftomenib Mexiletine Tamoxifen Deutivacaftor Teprenone ARTICAINE HYDROCHLORIDE DNL593 Binimetinib Lutetium (177Lu) Edotreotide PARECOXIB Fludrocortisone Acetate Aavanc80-5'Hotof Metamizole Sodium Monohydrate Enfuvirtide Cldn6 Car-T(A) Dexamethasone Base Sulfasalazine Zanamivir More therapies…

    Learn about Your Condition

    Body mass index increased Drug eruption Lichen planus Thalassaemia alpha Bile duct adenocarcinoma Endocarditis enterococcal Delayed graft function Mitral valve prolapse Retroperitoneal fibrosis Endocrine ophthalmopathy Skin candida Ovarian epithelial cancer Mixed-type liposarcoma Vertigo Nodal osteoarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Melpida with drug combination in patients with Hereditary Spastic Paraplegia Type 50 (SPG50)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Meglumine Gadoterate
    • Sirolimus
    • Lidocaine Hydrochloride Monohydrate
    Spain

  • Ropivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Mannitol
    Sweden

  • Randomized study of ketotifen nasal spray (0.025% and 0.050%) versus sodium cromoglicate nasal spray in patients with rhinitis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Cromoglicate
    Greece

  • Oral sodium hydrogen carbonate versus placebo to reduce assisted delivery in nulliparous women with prolonged labour

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Labour induction
    Investigated Drugs:
    • Sodium Hydrogen Carbonate
    Denmark

  • Obinutuzumab in patients with pure class V lupus nephritis (systemic lupus erythematosus membranous nephropathy) – phase II trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Obinutuzumab
    France

  • Efficacy of KITE-753 Compared with Axicabtagene Ciloleucel in Adults with Relapsed or Refractory Large B‑Cell Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    Belgium Czechia France Germany Italy The Netherlands +2
Previous Page
1 … 677 678 679 680 681 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!